Los Angeles Capital Management
IMGN

Los Angeles Capital Management’s Immunogen Inc IMGN Stock Holding History

Los Angeles Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,170
Closed -$1.25M – 1246
2023
Q4 		$1.25M Sell
42,170
-4,815
-10% -$95.9K ﹤0.01% 607
2023
Q3 		$746K Buy
46,985
+1,705
+4% +$28.4K ﹤0.01% 727
2023
Q2 		$854K Buy
+45,280
New +$535K ﹤0.01% 686
2021
Q4 		– Sell
-87,058
Closed -$494K – 1528
2021
Q3 		$494K Hold
87,058
– – ﹤0.01% 1046
2021
Q2 		$574K Sell
87,058
-11,290
-11% -$78.8K ﹤0.01% 1118
2021
Q1 		$797K Sell
98,348
-61,430
-38% -$502K ﹤0.01% 1009
2020
Q4 		$1.03M Buy
159,778
+40,780
+34% +$238K ﹤0.01% 933
2020
Q3 		$428K Sell
118,998
-100,480
-46% -$406K ﹤0.01% 1144
2020
Q2 		$1.01M Buy
219,478
+4,919
+2% +$20.9K ﹤0.01% 846
2020
Q1 		$732K Buy
214,559
+67,603
+46% +$296K ﹤0.01% 795
2019
Q4 		$750K Buy
+146,956
New +$499K ﹤0.01% 912
2019
Q3 		– Sell
-56,800
Closed -$123K – 1391
2019
Q2 		$123K Sell
56,800
-12,790
-18% -$30.2K ﹤0.01% 1313
2019
Q1 		$189K Sell
69,590
-8,320
-11% -$36K ﹤0.01% 1317
2018
Q4 		$374K Sell
77,910
-775
-1% -$4.7K ﹤0.01% 1039
2018
Q3 		$745K Sell
78,685
-3,470
-4% -$33.4K ﹤0.01% 976
2018
Q2 		$799K Buy
82,155
+64,740
+372% +$682K ﹤0.01% 979
2018
Q1 		$183K Buy
+17,415
New +$172K ﹤0.01% 1274
2017
Q1 		– Sell
-40,075
Closed -$82K – 1230
2016
Q4 		$82K Sell
40,075
-93,665
-70% -$188K ﹤0.01% 1143
2016
Q3 		$358K Sell
133,740
-1,675
-1% -$4.87K ﹤0.01% 1006
2016
Q2 		$417K Buy
+135,415
New +$849K ﹤0.01% 965

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Los Angeles Capital Management's IMGN Position: Q1 2024 in Review

Los Angeles Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 42,170 shares — an estimated $1.25M sold.

Los Angeles Capital Management first reported a position in IMGN in Q2 2016 and held it in 20 quarters. The position peaked at $1.25M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Los Angeles Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Los Angeles Capital Management sold 42,170 Immunogen Inc shares in Q1 2024, an estimated $1.25M.
  • Los Angeles Capital Management first reported a position in Immunogen Inc in Q2 2016 and held it in 20 quarters.
  • Los Angeles Capital Management's Immunogen Inc position peaked at $1.25M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Los Angeles Capital Management's 13F filing for Q1 2024, filed 5 Apr 2024.